Marban Linda's most recent trade in Capricor Therapeutics Inc was a trade of 25,000 Common Stock done at an average price of $1.4 . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 03 Mar 2025 | 25,000 | 223,604 (4%) | 0% | 1.4 | 34,750 | Common Stock |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Other type of transaction at price $ 0.00 per share. | 03 Mar 2025 | 12,500 | 211,104 (4%) | 0% | 0 | Common Stock | |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 210,000 | 210,000 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 34,962 | 34,962 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Marban Linda | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 9,633 | 9,633 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2023 | 41,497 | 0 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 12 May 2023 | 20,749 | 198,604 (4%) | 0% | 1.4 | 28,841 | Common Stock |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 377,830 | 377,830 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 458,693 | 458,693 | - | - | Stock Option (Right to Buy) |